glp-1 obesity drug news today october 2025 Retatrutide, the next generation of from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage clinical trial, the company announced. In It has been nearly Metabolism Type:Paperback

glp-1 obesity drug news today october 2025 Retatrutide, the next generation of from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage clinical trial, the company announced. In It has been nearly Metabolism Type:Paperback

It has been nearly 20 years since the introduction of the first approved glucagon-like peptide 1 receptor (GLP1R) agonist for the treatment of type 2 #diabetes and 10 years since the first

GLP-1 agonists could lead to worse metabolic health, including significant loss of muscle mass

Metabolism

Type:Paperback

These typically use a finger-prick method to collect a small blood sample, which you then mail back to the lab in a prepaid envelope